Table 1.
Controla | DAPAb | DOXc | DAPA + DOXd | P groups | P measures | |
---|---|---|---|---|---|---|
First weight measurement, g | 272.00 ± 36.72 | 299.60 ± 16.95 | 287.90 ± 17.51 | 287.10 ± 17.40 | <.001*
a–c a–d |
<.001* |
Second weight measurement, g | 301.40 ± 42.25 | 301.50 ± 15.23 | 273.40 ± 18.31 | 242.10 ± 21.08 | ||
Third weight measurement, g | 338.20 ± 43.37 | 325.00 ± 21.53 | 280.00 ± 21.00 | 265.33 ± 23.21 | ||
Fourth weight measurement, g | 338.10 ± 41.49 | 325.00 ± 22.45 | 275.50 ± 24.22 | 275.88 ± 21.24 | ||
Ejection fraction, baseline, % | 79.30 ± 2.40 | 79.10 ± 2.23 | 78.50 ± 2.46 | 78.00 ± 3.01 | <.001*
a–c |
<.001* |
Ejection fraction, week 6, % | 78.80 ± 2.57 | 80.90 ± 3.10 | 66.00 ± 9.98 | 74.00 ± 4.03 | ||
Fractional shortening baseline, % | 47.20 ± 3.88 | 47.20 ± 4.51 | 49.30 ± 5.20 | 46.70 ± 4.49 | .764 | <.001* |
Fractional shortening week 6, % | 48.10 ± 4.40 | 47.40 ± 4.76 | 43.20 ± 4.73 | 44.33 ± 3.80 | ||
End-diastolic volume baseline, μL | 275.70 ± 12.18 | 271.90 ± 15.83 | 269.20 ± 12.73 | 278.80 ± 22.92 | .141 | <.001* |
End-diastolic volume week 6, μL | 277.50 ± 11.22a | 269.65 ± 15.53b | 307.70 ± 35.32a.b | 284.11 ± 16.91 | ||
End-systolic volume baseline, μL | 57.50 ± 10.42 | 65.90 ± 7.63 | 55.00 ± 7.36a | 66.30 ± 11.64a | .205 | <.001* |
End-systolic volume week 6, μL | 59.10 ± 10.25 | 65.20 ± 8.09 | 68.70 ± 11.64 | 68.77 ± 10.38 | ||
Heart rate baseline, bpm | 331.30 ± 24.09 | 352.60 ± 28.96 | 358.10 ± 19.30 | 345.90 ± 28.51 | .026*
a–c |
.014 |
Heart rate week 6, bpm | 331.70 ± 24.77a | 354.40 ± 25.25 | 378.90 ± 42.82a | 348.33 ± 25.42 | ||
QTc baseline, ms | 171.40 ± 19.96 | 169.80 ± 17.11 | 170.90 ± 18.71 | 171.30 ± 17.99 | .525 | <.001* |
QTc week 6, ms | 171.80 ± 19.67 | 169.20 ± 14.92 | 192.30 ± 28.91 | 174.77 ± 16.72 | ||
QRS baseline, ms | 14.70 ± 2.21 | 14.90 ± 2.23 | 14.80 ± 2.74 | 15.00 ± 2.10 | .001*
a–c |
<.001* |
QRS week 6, ms | 14.90 ± 2.23a | 14.70 ± 2.11b | 23.10 ± 4.38a.b.c | 15.77 ± 1.92c |
Data are given as mean ± SD.
*Significant at the .05 level according to two-way repeated measure ANOVA.
a,b,c,dThe letters denote the significant pairwise study groups according to Dunnet t (2-sided) post-hoc test.
bpm, beat per minute; DAPA, dapagliflozin; DOX, doxorubicin; QTc, corrected QT interval.